BlackRock’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-127,743
| Closed | -$501K | – | 5556 |
|
|
2023
Q3 | $501K | Buy |
127,743
+74,204
| +139% | +$506K | ﹤0.01% | 4425 |
|
|
2023
Q2 | $174K | Sell |
53,539
-4,231
| -7% | -$12.6K | ﹤0.01% | 4765 |
|
|
2023
Q1 | $209K | Sell |
57,770
-3,864
| -6% | -$59.7K | ﹤0.01% | 4757 |
|
|
2022
Q4 | $1.98M | Buy |
61,634
+1,366
| +2% | +$54.1K | ﹤0.01% | 4139 |
|
|
2022
Q3 | $2.52M | Buy |
60,268
+14,720
| +32% | +$673K | ﹤0.01% | 4068 |
|
|
2022
Q2 | $1.92M | Sell |
45,548
-57,662
| -56% | -$2.67M | ﹤0.01% | 4262 |
|
|
2022
Q1 | $7M | Sell |
103,210
-2,157
| -2% | -$180K | ﹤0.01% | 3776 |
|
|
2021
Q4 | $12.8M | Buy |
105,367
+13,354
| +15% | +$2.25M | ﹤0.01% | 3524 |
|
|
2021
Q3 | $13M | Sell |
92,013
-162
| -0.2% | -$32.1K | ﹤0.01% | 3558 |
|
|
2021
Q2 | $25.3M | Buy |
92,175
+10,688
| +13% | +$2.7M | ﹤0.01% | 3152 |
|
|
2021
Q1 | $17.4M | Buy |
81,487
+16,474
| +25% | +$4.55M | ﹤0.01% | 3251 |
|
|
2020
Q4 | $15.7M | Buy |
65,013
+18,082
| +39% | +$2.24M | ﹤0.01% | 3134 |
|
|
2020
Q3 | $4.95M | Buy |
46,931
+5,880
| +14% | +$536K | ﹤0.01% | 3576 |
|
|
2020
Q2 | $4.02M | Buy |
41,051
+2,394
| +6% | +$210K | ﹤0.01% | 3607 |
|
|
2020
Q1 | $2.9M | Buy |
38,657
+954
| +3% | +$90.8K | ﹤0.01% | 3545 |
|
|
2019
Q4 | $3.06M | Buy |
37,703
+94
| +0.2% | +$10.5K | ﹤0.01% | 3650 |
|
|
2019
Q3 | $4.59M | Buy |
37,609
+4,871
| +15% | +$670K | ﹤0.01% | 3508 |
|
|
2019
Q2 | $5.88M | Buy |
32,738
+426
| +1% | +$68.9K | ﹤0.01% | 3483 |
|
|
2019
Q1 | $5.17M | Sell |
32,312
-1,235
| -4% | -$245K | ﹤0.01% | 3396 |
|
|
2018
Q4 | $8.73M | Buy |
33,547
+20,520
| +158% | +$4.13M | ﹤0.01% | 3165 |
|
|
2018
Q3 | $3.17M | Sell |
13,027
-60
| -0.5% | -$15.7K | ﹤0.01% | 3630 |
|
|
2018
Q2 | $3.09M | Buy |
+13,087
| New | +$3.82M | ﹤0.01% | 3611 |
|
